Nanoceria-Mediated Cyclosporin A Delivery for Dry Eye Disease Management through Modulating Immune–Epithelial CrosstalkWenyu Cui, Haijie Han, Sheng Chen et al.|ACS Nano|2024Cited by 67
Superiority of <scp>Low‐Dose</scp> Benzbromarone to <scp>Low‐Dose</scp> Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid UnderexcretionFei Yan, Changgui Li, Xiaomei Xue et al.|Arthritis & Rheumatology|2022Cited by 60
Biologically inspired bioactive hydrogels for scarless corneal repairHaijie Han, Tuoying Jiang, Jiqiao Qie et al.|Science Advances|2024Cited by 49
Response to febuxostat according to clinical subtypes of hyperuricemia: a prospective cohort study in primary goutHan Qi, Changgui Li, Mingshu Sun et al.|Arthritis Research & Therapy|2023Cited by 10
Cyclic cell-penetrating peptide-engineered ceria nanoparticles for non-invasive alleviation of ultraviolet radiation-induced cataractLuyang Jiang, Yibo Yu, Jinxia Liu et al.|Journal of Nanobiotechnology|2025Cited by 6